Market By Product, Application, And Geography | Forecast 2019-2028
As per Triton's research report, the Middle East and African opioid drugs market is anticipated to surge with a CAGR of 2.60% in the forecasting years of 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The coutnries scrutinized in this market are:
• Saudi Arbia
• Turkey
• The UAE
• South Africa
• Rest of MEA
Estimates from the WHO suggest that, nearly 60% of the total deaths in Gulf countries are related to non-communicable diseases. Increased consumption of tobacco and the lack of exercise are primarily attributable to the rise in the prevalence of these diseases. They cause immense pain to patients.
At a 2017 summit organized in Muscat, Oman, representatives from the countries in the Gulf agreed on following procedures required to fight chronic disease. This also included fighting chronic pain, which, is proving beneficial for the growth of the studied market, as opioid drugs help alleviate pain. Approximately half of the patients dying from chronic diseases in these nations die prematurely, before 60 years of age. The initiatives taken by the countries in the GCC is a major step towards controlling premature deaths. Besides, this initiative is also offering opportunities for pain management, which is the primary driving force behind the growth of the opioid drugs market in this region.
In the United Arab Emirates, palliative care is limited to only two hospitals, namely, Al-Ain city's Tawam hospital and Dubai's American hospital. Due to the sparsely available services in the country, it has been included in the list of "Group 3 countries" for palliative care by the WHO. This is proving extremely challenging to cancer patients, as they cannot receive the best treatment. This is majorly hindering the market growth in the UAE.
Lupin Limited is a manufacturer of actives and formulations. Hydrocodone Bitartrate & Acetaminophen Tablets USP, Morphine Sulfate, and Oxycodone Hydrochloride Tablets USP are the opioids offered by the company. Lupin boasts of a highly-skilled research team consisting of a workforce of more than 1,500 R&D individuals. The company as a notable presence in South Africa.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1.   MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET - SUMMARY
2.   INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.2.1. TECHNOLOGICAL ADVANCEMENTS TO FIGHT AGAINST OPIOID DRUG CRISIS
2.2.2. DIFFERENT SOURCES OF PROCURING OPIOIDS
2.3. PORTER’S FIVE FORCE ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE
2.3.3. BARGAINING POWER OF SUPPLIERS
2.3.4. BARGAINING POWER OF BUYERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. MARKET DRIVERS
2.6.1. GROWTH IN MEDICAL CASES & RISING PREVALENCE OF CANCER
2.6.2. INCREASE IN THE USE OF ABUSE-DETERRENT FORMULATIONS TO RESTRICT THE RISE OF OPIOID DEPENDENCE
2.6.3. DEMAND FOR PALLIATIVE THERAPY
2.7. MARKET RESTRAINTS
2.7.1. GOVERNMENT RULES AND REGULATIONS
2.7.2. INCREASED NUMBER OF LAWSUITS AGAINST THE MANUFACTURERS OF OPIOD DRUGS
2.7.3. USAGE OF OPIOIDS FOR NON-MEDICAL PURPOSES
2.8. MARKET OPPORTUNITIES
2.8.1. RISING COMMERCIAL SUCCESS AND MARKET SHARE OF OPIOID DRUGS
2.8.2. GROWTH OF INVESTMENTS IN RESEARCH OF PHARMACEUTICAL USES OF OPIOIDS
2.9. MARKET CHALLENGES
2.9.1. OPIOID EPIDEMIC SPREADING
2.9.2. RISING DEATH RATE DUE TO OPIOID OVERDOSE
2.10. COVID-19 IMPACT ON THE OPIOID DRUGS MARKET
3.   MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET OUTLOOK - BY PRODUCT
3.1. BUPRENORPHINE
3.2. FENTANYL
3.3. HYDROCODONE
3.4. MORPHINE
3.5. OXYCODONE
3.6. TRAMADOL
3.7. OTHER PRODUCTS
4.   MIDDLE EAST AND AFRICA OPIOID DRUGSS MARKET OUTLOOK - BY APPLICATION
4.1. PAIN RELIEF
4.1.1. CANCER PAIN
4.1.2. POSTOPERATIVE PAIN MANAGEMENT
4.1.3. LOWER BACK PAIN
4.1.4. ORTHOPEDIC
4.1.5. NEUROPATHIC
4.1.6. FIBROMYALGIA
4.2. ANESTHESIA
4.3. COUGH SUPPRESSION
4.4. DIARRHEA SUPPRESSION
4.5. DE-ADDICTION
5.   MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET – REGIONAL OUTLOOK
5.1. UNITED ARAB EMIRATES
5.2. TURKEY
5.3. SAUDI ARABIA
5.4. SOUTH AFRICA
5.5. REST OF MIDDLE EAST AND AFRICA
6.   COMPETITIVE LANDSCAPE
6.1. ACURA PHARMACEUTICALS
6.2. BIODELIVERY SCIENCES INTERNATIONAL INC
6.3. CIPHER PHARMACEUTICALS INC
6.4. ALLERGAN (ACQUIRED BY ABBVIE)
6.5. COLLEGIUM PHARMACEUTICAL INC
6.6. DAIICHI SANKYO
6.7. HIKMA PHARMACEUTICALS PLC
6.8. INDIVIOR INC
6.9. JANSSEN PHARMACEUTICALS INC
6.10. JOHNSON JOHNSON
6.11. LANNETT CO INC
6.12. LUPIN LTD
6.13. MYLAN NV
6.14. PFIZER INC
6.15. PURDUE PHARMA LP
6.16. SANOFI-AVENTIS SA
6.17. SUN PHARMACEUTICAL INDUSTRIES LTD
6.18. TEVA PHARMACEUTICAL INDUSTRIES LTD
7.   METHODOLOGY & SCOPE
7.1. RESEARCH SCOPE & DELIVERABLES
7.2. SOURCES OF DATA
7.3. RESEARCH METHODOLOGY
TABLE 1: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE 4: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 5: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY PAIN RELIEF, 2019-2028 (IN $ MILLION)
TABLE 6: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
FIGURE 1: PORTER’S FIVE FORCE ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY BUPRENORPHINE, 2019-2028 (IN $ MILLION)
FIGURE 4: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY FENTANYL, 2019-2028 (IN $ MILLION)
FIGURE 5: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY HYDROCODONE, 2019-2028 (IN $ MILLION)
FIGURE 6: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY MORPHINE, 2019-2028 (IN $ MILLION)
FIGURE 7: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY OXYCODONE, 2019-2028 (IN $ MILLION)
FIGURE 8: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY TRAMADOL, 2019-2028 (IN $ MILLION)
FIGURE 9: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY OTHER PRODUCTS, 2019-2028 (IN $ MILLION)
FIGURE 10: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY PAIN RELIEF, 2019-2028 (IN $ MILLION)
FIGURE 11: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY CANCER PAIN, 2019-2028 (IN $ MILLION)
FIGURE 12: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY POSTOPERATIVE PAIN MANAGEMENT, 2019-2028 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY LOWER BACK PAIN, 2019-2028 (IN $ MILLION)
FIGURE 14: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY ORTHOPEDIC, 2019-2028 (IN $ MILLION)
FIGURE 15: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY NEUROPATHIC, 2019-2028 (IN $ MILLION)
FIGURE 16: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY FIBROMYALGIA, 2019-2028 (IN $ MILLION)
FIGURE 17: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY ANESTHESIA 2019-2028, (IN $ MILLION)
FIGURE 18: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY COUGH SUPPRESSION, 2019-2028 (IN $ MILLION)
FIGURE 19: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY DIARRHEA SUPPRESSION 2019-2028 (IN $ MILLION)
FIGURE 20: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY DE-ADDICTION, 2019-2028 (IN $ MILLION)
FIGURE 21: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET; REGIONAL OUTLOOK 2019 & 2028 (IN %)
FIGURE 22: UNITED ARAB EMIRATES OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 23: TURKEY OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 24: SAUDI ARABIA OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 25: SOUTH AFRICA OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 26: REST OF MIDDLE EAST & AFRICA OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)